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Simon D. Robinson, MBCHB, BSC, MD
Victoria, British Columbia, CanadaTranscatheter aortic valve replacement (TAVR) is
increasingly being used to treat patients with severe
aortic stenosis who are either deemed to be inop-
erable or at prohibitive surgical risk (1). Both
operator experience and devices have evolved over
time, as have the indications for valve implantation.
We present the case of a 92-year-old woman
with symptomatic aortic stenosis (area, 0.7 cm2;
peak/mean gradients, 45/24 mm Hg, respectively;
ejection fraction, 55%), stable coronary artery dis-
ease, hypertension, and peripheral vascular disease
who was deemed to be inoperable due to the
presence of a porcelain aorta.Figure 1. Transthoracic Echocardiogram
Parasternal Long-Axis View
This view demonstrates that the sinus of Valsalva aneurysm
limited to the right coronary cusp (solid arrows) and measures
4.6 cm in its maximal dimension.
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sinus of Valsalva limited to the right coronary cusp
that was detected on transthoracic echocardiogra-
phy (Fig. 1). This ﬁnding was conﬁrmed by
aortography (Fig. 2) and computed tomography
(CT) (Fig. 3).
The presence of a sinus of Valsalva aneurysm,
although not a contraindication to TAVR, could
conceivably increase the risk of aortic rupture, a
rare, but potentially devastating complication (2,3),Figure 2. Aortogram Obtained in the Right
Anterior Oblique Projection
Extensive aortic calciﬁcation (frequently referred to as porcelain
aorta) is highlighted by the white arrow, and the saccular
aneurysm of the sinus of Valsalva (black arrow) is seen to be
limited to the right coronary cusp.
Figure 3. Short-Axis View Obtained by Computed Tomography
This view clearly shows the saccular aneurysm, which is limited to the right
coronary cusp of the sinus of Valsalva (arrow). Calciﬁcation of the aortic valve
cusps is also noted.
Figure 5. Computed Tomography of the Thorax With Contrast
After Transcutaneous Aortic Valve Implantation
The 26-mm CoreValve (Medtronic, Minneapolis, Minnesota) is seen in place
(white arrow), and there is seen to be reduced ﬁlling of the aneurysm. The
valve is seen to be well apposed to the aortic wall.
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e30during pre-dilation or valve deployment. We elected there-
fore to implant a self-expandable Medtronic CoreValve to
minimize this risk (because it does not require balloon
inﬂation to deploy the valve), while performing only modest
pre-dilation with an 18-mm NuCLEUS balloon (NuMed
Canada, Inc., Cornwall, Ontario, Canada). A 26-mm
Medtronic CoreValve (Minneapolis, Minnesota) (based onFigure 4. Aortogram Obtained During CoreValve Implantation
Aortogram showing improved appearance of aneurysm immediately after
CoreValve (Medtronic, Minneapolis, Minnesota) deployment (shallow left
anterior oblique-caudal view).CT dimensions) was then deployed safely under rapid pac-
ing, and the subsequent aortogram (Fig. 4) showed the valve
to be well deployed, with reduced ﬁlling of the aneurysm.
This was later conﬁrmed by CT scan (Fig. 5).
This case demonstrates that inoperable patients with
aortic stenosis and a concomitant sinus of Valsalva aneurysm
may be treated safely in selected situations by TAVR with a
self-expandable transcatheter valve.
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